Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 2261  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
   Next article
   Previous article 
   Table of Contents
 Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (46 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this Article

 Article Access Statistics
    PDF Downloaded67    
    Comments [Add]    

Recommend this journal


Year : 2005  |  Volume : 53  |  Issue : 1  |  Page : 71-72

Invited Comments

Bangalore, India

Correspondence Address:
H V Srinivas
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

How to cite this article:
Srinivas H V. Invited Comments. Neurol India 2005;53:71-2

How to cite this URL:
Srinivas H V. Invited Comments. Neurol India [serial online] 2005 [cited 2022 Oct 2];53:71-2. Available from: https://www.neurologyindia.com/text.asp?2005/53/1/71/15062

Epilepsy today is an eminently treatable condition in nearly 70-80% patients. However, there is a small but significant 20-25% who continue to have seizures, in spite of appropriate and adequate antiepileptic drug therapy. Surgical treatment is a very good option for people with medically refractory temporal lobe epilepsy, which is gaining ground and being practiced worldwide. Though surgical results have been very encouraging we still need to fine-tune the selection criteria to improve the results further and ask the question why every patient is not benefited? As a corollary, maybe there is a need to identify the factors to reject the surgical option.

MRI has greatly contributed to the selection of cases by delineating structural abnormalities, largely hippocompal atrophy. It stands to reason that if a lesion is responsible for medically refractory temporal lobe epilepsy lesionectomy should give excellent results. This article focuses on a subtype of a structural temporal lobe lesion i.e. tumoral lesion. Seizure freedom was achieved in nearly 80% of the patients, one-third of them without antiepileptic drugs and 75% seizure reduction in 90% of the patients. If the tumor is involving the mesial temporal lobe structures, these too need to be resected. Incomplete tumor resection is an important cause for continued seizures in the postoperative period. It would have been worthwhile to have done postoperative MRI in all the cases (economically difficult proposition!) to know how many had residual tumor, but yet were free from seizures. From the clinical point of view the most important observation is the seizure-free period during the first postoperative year, which portends excellent long-term prognosis.


Print this article  Email this article
Previous article Next article
Online since 20th March '04
Published by Wolters Kluwer - Medknow